[Allergic rhinitis].
Okamoto
Yoshitaka
Y
Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000502:physiology; D018925:Chemokines / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D003888:Desensitization, Immunologic; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D019444:Vaccines, DNA / Q000627:therapeutic use; D022223:Vaccines, Subunit / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D001500:BCG Vaccine; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines; D006633:Histamine Antagonists; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; C401983:rhuMAb-E25